ロード中...
An assessment of the tolerability of moxifloxacin 0.5% compared to azithromycin 1.0% in DuraSite(®)
This subject-masked, randomized, active and placebo-controlled study compared subjects’ perceptions of two antibiotic ophthalmic drops. One hundred and twenty-five healthy volunteers received two of the following solutions: moxifloxacin 0.5% ophthalmic solution (Vigamox(®), Alcon Laboratories, Inc.,...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2007
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2704531/ https://ncbi.nlm.nih.gov/pubmed/19668531 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|